92 related articles for article (PubMed ID: 9192809)
1. Expression of the tumor-associated gene MN: a potential biomarker for human renal cell carcinoma.
McKiernan JM; Buttyan R; Bander NH; Stifelman MD; Katz AE; Chen MW; Olsson CA; Sawczuk IS
Cancer Res; 1997 Jun; 57(12):2362-5. PubMed ID: 9192809
[TBL] [Abstract][Full Text] [Related]
2. The expression of G250/mn/CA9 antigen by flow cytometry: its possible implication for detection of micrometastatic renal cancer cells.
Li G; Passebosc-Faure K; Lambert C; Gentil-Perret A; Blanc F; Oosterwijk E; Mosnier JF; Genin C; Tostain J
Clin Cancer Res; 2001 Jan; 7(1):89-92. PubMed ID: 11205923
[TBL] [Abstract][Full Text] [Related]
3. MN/CA IX/G250 as a potential target for immunotherapy of renal cell carcinomas.
Uemura H; Nakagawa Y; Yoshida K; Saga S; Yoshikawa K; Hirao Y; Oosterwijk E
Br J Cancer; 1999 Oct; 81(4):741-6. PubMed ID: 10574265
[TBL] [Abstract][Full Text] [Related]
4. [MN/CA IX antigen as a potential target for renal cell carcinoma].
Uemura H; Cho M; Nakagawa Y; Shimizu K; Yoshikawa M; Kim S; Hirao Y
Hinyokika Kiyo; 2000 Oct; 46(10):745-8. PubMed ID: 11215204
[TBL] [Abstract][Full Text] [Related]
5. [Value of MN/CAIX in the diagnosis of renal cell carcinoma].
Jiang YD; Ren F; Zheng SB
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Mar; 32(3):412-4. PubMed ID: 22445996
[TBL] [Abstract][Full Text] [Related]
6. [The role of MN/CA IX antigen in carcinogenesis and metastasis of renal cell carcinoma].
Nakagawa Y; Uemura H; Shimizu K; Cho M; Yoshikawa M; Hirao Y; Yoshikawa K
Hinyokika Kiyo; 2001 Nov; 47(11):809-14. PubMed ID: 11771176
[TBL] [Abstract][Full Text] [Related]
7. Identification of the MN/CA9 protein as a reliable diagnostic biomarker of clear cell carcinoma of the kidney.
Liao SY; Aurelio ON; Jan K; Zavada J; Stanbridge EJ
Cancer Res; 1997 Jul; 57(14):2827-31. PubMed ID: 9230182
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical study of colorectal tumors for expression of a novel transmembrane carbonic anhydrase, MN/CA IX, with potential value as a marker of cell proliferation.
Saarnio J; Parkkila S; Parkkila AK; Haukipuro K; Pastoreková S; Pastorek J; Kairaluoma MI; Karttunen TJ
Am J Pathol; 1998 Jul; 153(1):279-85. PubMed ID: 9665489
[TBL] [Abstract][Full Text] [Related]
9. A study of biomarkers in cervical carcinoma and clinical correlation of the novel biomarker MN.
Brewer CA; Liao SY; Wilczynski SP; Pastorekova S; Pastorek J; Zavada J; Kurosaki T; Manetta A; Berman ML; DiSaia PJ; Stanbridge EJ
Gynecol Oncol; 1996 Dec; 63(3):337-44. PubMed ID: 8946869
[TBL] [Abstract][Full Text] [Related]
10. [Detection of carbonic anhydrase IX gene expression in renal cell carcinoma with reverse transcription-PCR].
Jiang YD; Zheng SB; Wang ZH
Di Yi Jun Yi Da Xue Xue Bao; 2004 Jan; 24(1):99-101. PubMed ID: 14724112
[TBL] [Abstract][Full Text] [Related]
11. Blood-based RT-PCR assays of MN/CA9 or PSMA: clinical application in renal cancer patients.
de la Taille A; Katz A; Cao Y; McKiernan J; Buttyan R; Burchardt M; Burchardt T; Hayek O; Olsson CA; Chopin DK; Sawczuk IS
Urology; 2000 Sep; 56(3):393-8. PubMed ID: 10962301
[TBL] [Abstract][Full Text] [Related]
12. A potential for tissue restrictive gene therapy in renal cell carcinoma using MN/CA IX promoter.
Ou YC; Gardner TA; Kao C; Zhau HE; Chung LW
Anticancer Res; 2005; 25(2A):881-6. PubMed ID: 15868923
[TBL] [Abstract][Full Text] [Related]
13. Detection of circulating MN/CA9 positive renal cell carcinoma cells during operation.
Uemura H; Nakagawa Y; Iwai A; Okajima E; Okajima E; Yoshikawa K; Hirao Y
Aktuelle Urol; 2003 Jul; 34(4):270-2. PubMed ID: 14566683
[TBL] [Abstract][Full Text] [Related]
14. Kidney cancer: Carbonic anhydrase IX in resected clear cell RCC.
Pickering LM; Larkin J
Nat Rev Urol; 2015 Jun; 12(6):309-10. PubMed ID: 26032554
[No Abstract] [Full Text] [Related]
15. [Molecular detection of circulating cancer cells in patients with renal cell carcinoma].
Uemura H
Hinyokika Kiyo; 1999 Aug; 45(8):571-5. PubMed ID: 10500965
[TBL] [Abstract][Full Text] [Related]
16. Current status and future directions of molecular markers in renal cell carcinoma.
Rini BI
Curr Opin Urol; 2006 Sep; 16(5):332-6. PubMed ID: 16905977
[TBL] [Abstract][Full Text] [Related]
17. Study of in vitro conditions modulating expression of MN/CA IX protein in human cell lines derived from cervical carcinoma.
Lieskovská J; Opavský R; Záciková L; Glasová M; Pastorek J; Pastoreková S
Neoplasma; 1999; 46(1):17-24. PubMed ID: 10355529
[TBL] [Abstract][Full Text] [Related]
18. The use of MN/CA9 gene expression in identifying malignant solid renal tumors.
Li G; Cuilleron M; Cottier M; Gentil-Perret A; Lambert C; Genin C; Tostain J
Eur Urol; 2006 Feb; 49(2):401-5. PubMed ID: 16387417
[TBL] [Abstract][Full Text] [Related]
19. Carbonic anhydrase IX as a predictive biomarker for clear cell renal cell carcinoma.
Pantuck AJ; Klatte T; Seligson D; Atkins M; Belldegrun A
J Clin Oncol; 2008 Jun; 26(18):3105-7; author reply 3107-9. PubMed ID: 18565906
[No Abstract] [Full Text] [Related]
20. MN/CA9 gene expression as a potential biomarker in renal cell carcinoma.
Murakami Y; Kanda K; Tsuji M; Kanayama H; Kagawa S
BJU Int; 1999 May; 83(7):743-7. PubMed ID: 10368188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
